North America & Europe Age-related Macular Degeneration Therapeutics Market, By Disease Type (Dry AMD, and Wet AMD), By Drug Type (Aflibercept (Eylea), Ranibizumab (Lucentis), Bevacizumab (Avastin), Pegaptanib (Macugen), Verteporfin (Visudyne), Brolucizum

North America & Europe Age-related Macular Degeneration Therapeutics Market, By Disease Type (Dry AMD, and Wet AMD), By Drug Type (Aflibercept (Eylea), Ranibizumab (Lucentis), Bevacizumab (Avastin), Pegaptanib (Macugen), Verteporfin (Visudyne), Brolucizumab (Beovu), Supplements, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America and Europe) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Age-related macular degeneration is one of the most common causes of blindness among the elderly population. The geriatric population is highly susceptible to different types of age-related diseases such as diabetes, renal insufficiency, arthritis, and macular degeneration. According to an article published in the BrightFocus Foundation in January 2019, the risk of getting affected by advanced age-related macular degeneration for people of age group of 50-59 is 2%, whereas it is around 30% among those who are over the age of 75 years. Hence, the high risk of age-related macular degeneration in geriatric population is anticipated to drive the growth of age-related macular degeneration therapeutics market during the forecast period.

Market Dynamics

Majority of pharmaceutical manufacturers operating in the North America & Europe age-related macular degeneration treatment market are engaged in adoption of inorganic growth strategies such as collaborations, partnerships, and acquisitions to strengthen their market share. These strategies have enabled market players to develop new drugs for treating AMD and enhance their existing portfolio of retinal products. For instance, in January 2020, Exonate, an early stage biotechnology company, collaborated with Janssen Pharmaceuticals, Inc., a pharmaceutical companies of Johnson & Johnson, to develop an eye drop treatment for retinal vascular diseases such as wet age-related macular degeneration treatment and diabetic macular oedema (DMO by using mRNA targeted therapies).

Key features of the study:

  • This report provides in-depth analysis of the North America & Europe age-related macular degeneration therapeutics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the North America & Europe age-related macular degeneration therapeutics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Novartis AG, Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Pfizer, Inc., and Valeant Pharmaceuticals International, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, type up-gradation, market expansion, and marketing tactics
  • The North America & Europe age-related macular degeneration therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America & Europe age-related macular degeneration therapeutics market.
>Detailed Segmentation:
  • North America & Europe Age-related Macular Degeneration Therapeutics Market, By Disease Type:
  • Dry AMD
  • Wet AMD
  • North America & Europe Age-related Macular Degeneration Therapeutics Market, By Drug Type:
  • Aflibercept (Eylea)
  • Ranibizumab (Lucentis)
  • Bevacizumab (Avastin)
  • Pegaptanib (Macugen)
  • Verteporfin (Visudyne)
  • Brolucizumab (Beovu)
  • Supplements
  • Others
  • North America & Europe Age-related Macular Degeneration Therapeutics Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • North America & Europe Age-related Macular Degeneration Therapeutics Market, By Region:
  • North America
  • By Disease Type:
  • Dry AMD
  • Wet AMD
  • By Drug Type
  • Aflibercept (Eylea)
  • Ranibizumab (Lucentis)
  • Bevacizumab (Avastin)
  • Pegaptanib (Macugen)
  • Verteporfin (Visudyne)
  • Brolucizumab (Beovu)
  • Supplements
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Disease Type:
  • Dry AMD
  • Wet AMD
  • By Drug Type
  • Aflibercept (Eylea)
  • Ranibizumab (Lucentis)
  • Bevacizumab (Avastin)
  • Pegaptanib (Macugen)
  • Verteporfin (Visudyne)
  • Brolucizumab (Beovu)
  • Supplements
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Company Profiles
  • Novartis AG*
  • Company Overview
  • Material Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Bayer AG
  • Bausch Health Companies Inc.
  • Regeneron Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche AG
  • Pfizer, Inc.
  • Valeant Pharmaceuticals International, Inc.
> “*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Disease Type
Market Snippet, By Drug Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
PEST Analysis
4. North America & Europe Age-related Macular Degeneration Therapeutics Market – Impact of Coronavirus (Covid-19) Pandemic
Impact assessment
Pre COVID-19 Market Scenario
Post COVID-19 Market Scenario
Government measures to combat COVID-19
1. North America & Europe Age-related Macular Degeneration Therapeutics Market, By Disease Type, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Dry AMD
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Wet AMD
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
2. North America & Europe Age-related Macular Degeneration Therapeutics Market, By Drug Type, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Aflibercept (Eylea)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Ranibizumab (Lucentis)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Bevacizumab (Avastin)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Pegaptanib (Macugen)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Verteporfin (Visudyne)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Brolucizumab (Beovu)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Supplements
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
3. North America & Europe Age-related Macular Degeneration Therapeutics Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
4. North America & Europe Age-related Macular Degeneration Therapeutics Market, By Region, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2020 and 2027 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2027
North America
Market Size and Forecast, By Disease Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Disease Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
5. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Novartis AG
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Bayer AG
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Bausch Health Companies Inc.
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Regeneron Pharmaceuticals, Inc.
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
F. Hoffmann-La Roche AG
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Pfizer, Inc.
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Valeant Pharmaceuticals International, Inc.
Company Overview
Device Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
6. Section
References
Research Methodology
About us and Sales Contact
*Browse 46 market data tables and 37 figures on "Age-related Macular Degeneration Therapeutics Market” – North America & Europe forecast to 2027

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook